coronary artery disease. Atherosclerotic heart disease
Conditions
Interventions
Intervention 1: Home-based exercise rehabilitation group: The subjects in this group participated in aerobic and resistance exercise at home for 8 weeks, 3 sessions per week about 60-90 minutes. The H
Rehabilitation
Home-based exercise rehabilitation group: The subjects in this group participated in aerobic and resistance exercise at home for 8 weeks, 3 sessions per week about 60-90 minutes. The Home-based exerci
Centre-based cardiac rehabilitation group: During the study period of 8 weeks, all the study subjects participated 3 exercise sessions last 60-90 minutes, per week. The subjects in this group followed
control group: the control group was only followed-up and during this period they did not experience any exercise
Sponsors
University of Isfahan, Faculty of Physical Education & Sport Science
Eligibility
Sex/Gender
All
Age
45 Years to 68 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with coronary artery disease after coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI); 3 months after coronary artery bypass surgery or coronary angioplasty; Surgical repair in patients. Exclusion criteria: Any adverse conditions or obstacles that interfere exercise intervention and assess the effectiveness of the training program is difficult; Diseases such as uncontrolled hypertension, arthritis, respiratory diseases, acute orthopedic problems and musculoskeletal pain were included; regular exercise Before entering the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| LDH. Timepoint: The bigining and the end of the intervention. Method of measurement: U/L, Laboratory measurements.;SGOT. Timepoint: The bigining and the end of the intervention. Method of measurement: U/L, Laboratory measurements.;SGPT. Timepoint: The bigining and the end of the intervention. Method of measurement: U/L, Laboratory measurements.;ALK. Timepoint: The bigining and the end of the intervention. Method of measurement: U/L, Laboratory measurements.;HDL. Timepoint: The bigining and the end of the intervention. Method of measurement: Mg/dl, Laboratory measurements.;FBS. Timepoint: The bigining and the end of the intervention. Method of measurement: Mg/dl, Laboratory measurements.;CBC. Timepoint: The bigining and the end of the intervention. Method of measurement: Laboratory measurements.;LDL. Timepoint: The bigining and the end of the intervention. Method of measurement: Mg/dl, Laboratory measurements.;Cholesterol. Timepoint: The bigining and the end of the intervention. Method of measurement: Mg/dl, Laboratory measurements.;Triglyceride. Timepoint: The bigining and the end of the intervention. Method of measurement: Mg/dl, Laboratory measurements.;Quality of life. Timepoint: The bigining and the end of the intervention. Method of measurement: Questionnaire SF36.;Anxiety. Timepoint: The bigining and the end of the intervention. Method of measurement: Questionnaire S.A.S.;Depretion. Timepoint: The bigining and the end of the intervention. Method of measurement: Questionnaire Beck.;Type A behavior. Timepoint: The bigining and the end of the intervention. Method of measurement: Questionnaire TAB.;Systolic blood pressure. Timepoint: The bigining and the end of the intervention. Method of measurement: Mercury sphygmomanometer, mmHg.;Diastolic blood pressure. Timepoint: The bigining and the end of the intervention. Method of measurement: Mercury sphygmomanometer, mmHg. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzam Moosavi Sohroforouzani
University of Isfahan
Outcome results
None listed